CN102675122A - A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine - Google Patents
A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine Download PDFInfo
- Publication number
- CN102675122A CN102675122A CN2012100099450A CN201210009945A CN102675122A CN 102675122 A CN102675122 A CN 102675122A CN 2012100099450 A CN2012100099450 A CN 2012100099450A CN 201210009945 A CN201210009945 A CN 201210009945A CN 102675122 A CN102675122 A CN 102675122A
- Authority
- CN
- China
- Prior art keywords
- dihydro
- amine
- inden
- reaction
- indene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229910000761 Aluminium amalgam Inorganic materials 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- ATEGUFMEFAGONB-UHFFFAOYSA-N n-(2,3-dihydroinden-1-ylidene)hydroxylamine Chemical compound C1=CC=C2C(=NO)CCC2=C1 ATEGUFMEFAGONB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 11
- 229910052782 aluminium Inorganic materials 0.000 claims description 9
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 238000006722 reduction reaction Methods 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000004809 thin layer chromatography Methods 0.000 claims description 4
- 239000010779 crude oil Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000002730 mercury Chemical class 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- JDBJJCWRXSVHOQ-UTONKHPSSA-N methanesulfonic acid;(1r)-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound CS(O)(=O)=O.C1=CC=C2[C@H](NCC#C)CCC2=C1 JDBJJCWRXSVHOQ-UTONKHPSSA-N 0.000 abstract description 9
- 229960001956 rasagiline mesylate Drugs 0.000 abstract description 7
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000003756 stirring Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 4
- 229960000245 rasagiline Drugs 0.000 description 4
- RUOKEQAAGRXIBM-GFCCVEGCSA-N rasagiline Chemical compound C1=CC=C2[C@H](NCC#C)CCC2=C1 RUOKEQAAGRXIBM-GFCCVEGCSA-N 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 3
- 229910000370 mercury sulfate Inorganic materials 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 2
- YGKHOZXCTLKSLJ-KHAGDFGNSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(1r)-n-prop-2-ynyl-2,3-dihydro-1h-inden-1-amine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1=CC=C2[C@H](NCC#C)CCC2=C1.C1=CC=C2[C@H](NCC#C)CCC2=C1 YGKHOZXCTLKSLJ-KHAGDFGNSA-N 0.000 description 1
- MHQIZLXEJZNBQI-UHFFFAOYSA-N 1h-inden-1-amine Chemical compound C1=CC=C2C(N)C=CC2=C1 MHQIZLXEJZNBQI-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940031774 azilect Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- FXXOTIUPVOHDQK-UHFFFAOYSA-N prop-1-ynyl 4-methylbenzenesulfonate Chemical compound CC#COS(=O)(=O)C1=CC=C(C)C=C1 FXXOTIUPVOHDQK-UHFFFAOYSA-N 0.000 description 1
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 1
- 229950010683 rasagiline tartrate Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 description 1
- 229960003946 selegiline Drugs 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及医药技术领域,尤其是指一种2,3-二氢-1H-茚-1-胺的制备工艺,本本发明的合成甲磺酸雷沙吉兰的中间体2,3-二氢-1H-茚-1-胺的制备工艺,采用2,3-二氢-1H-茚-1-酮肟在乙醇水溶液中用铝汞齐还原制得2,3-二氢-1H-茚-1-胺,达到低成本合成2,3-二氢-1H-茚-1-胺的目的,本发明工艺具有工艺简单,成本低廉,操作简易,无危险性,收率高的特点。The invention relates to the field of medical technology, and in particular to a preparation process of 2,3-dihydro-1H-inden-1-amine. The invention relates to the preparation process of 2,3-dihydro-1H-inden-1-amine, an intermediate for synthesizing rasagiline mesylate. 2,3-dihydro-1H-inden-1-one oxime is reduced with aluminum amalgam in an ethanol aqueous solution to prepare 2,3-dihydro-1H-inden-1-amine, so as to achieve the purpose of synthesizing 2,3-dihydro-1H-inden-1-amine at low cost. The process of the invention has the characteristics of simple process, low cost, easy operation, no danger and high yield.
Description
技术领域 technical field
本发明涉及医药技术领域,尤其是指一种2,3-二氢-1H-茚-1-胺的制备工艺。 The invention relates to the technical field of medicine, in particular to a preparation process of 2,3-dihydro-1H-inden-1-amine. the
背景技术 Background technique
2,3-二氢-1H-茚-1-胺是合成甲磺酸雷沙吉兰的中间体,甲磺酸雷沙吉兰(rasagiline mesylate,Agilect),是一种新颖、有效的第2代选择性MAo-B抑制剂。该药于2005年1月第1次获准在以色列上市,随后于2005年2月获欧盟批准,2005年6月首次在欧盟国家英国上市,2006年,FDA批准雷沙吉兰在美国上市,商品名为Azilect,用于初始单药治疗早期帕金森病,且可作为较晚期患者治疗药物左旋多巴的补充用药。与第1代MAo-B抑制剂司来吉兰相比,疗效更好,副作用更少等优点。2,3-二氢-1H-茚-1-胺结构式如下(式II): 2,3-Dihydro-1H-indene-1-amine is an intermediate for the synthesis of rasagiline mesylate, and rasagiline mesylate (Agilect) is a novel and effective second Generation of selective MAo-B inhibitors. The drug was approved for marketing in Israel for the first time in January 2005, and was subsequently approved by the European Union in February 2005. It was first launched in the EU country UK in June 2005. In 2006, FDA approved rasagiline to be marketed in the United States. Named Azilect, it is used as an initial monotherapy for early-stage Parkinson's disease and as a supplement to levodopa in more advanced patients. Compared with the first-generation MAo-B inhibitor selegiline, it has better efficacy and fewer side effects. 2,3-dihydro-1H-inden-1-amine structural formula is as follows (formula II):
式II Formula II
目前,2,3-二氢-1H-茚-1-胺的合成主要有以下几种方法: At present, the synthesis of 2,3-dihydro-1H-inden-1-amine mainly contains the following methods:
中国新药杂志2003年第12卷第6期报道了一种2,3-二氢-1H-茚-1-胺合成方法,该方法以2,3-二氢-1H-茚-1-酮肟为原料,在乙二醇二甲醚溶剂中用四氯化钛和硼氢化钠还原制得2,3-二氢-1H-茚-1-胺,收率83.0%。该法使用四氯化钛和硼氢化钠,试剂比较昂贵,操作复杂,成本较高。 The 6th issue of the 12th volume of China's new drug magazine in 2003 reported a kind of 2,3-dihydro-1H-inden-1-amine synthetic method, and this method uses 2,3-dihydro-1H-inden-1-one oxime As a raw material, 2,3-dihydro-1H-indene-1-amine was obtained by reduction with titanium tetrachloride and sodium borohydride in ethylene glycol dimethyl ether solvent, with a yield of 83.0%. This method uses titanium tetrachloride and sodium borohydride, the reagents are relatively expensive, the operation is complicated, and the cost is high. the
WO02/068376A1以2,3-二氢-1H-茚-1-酮为原料,与苄胺缩合反应生成亚 胺,亚胺经硼氢化钠还原制得胺,然后脱去苄基得到1-茚胺。该方法步骤多,同样用到硼氢化钠,收率不高,成本较高。 WO02/068376A1 uses 2,3-dihydro-1H-inden-1-one as a raw material to condense with benzylamine to form an imine, and the imine is reduced by sodium borohydride to obtain an amine, and then the benzyl group is removed to obtain 1-indene amine. The method has many steps and also uses sodium borohydride, so the yield is not high and the cost is high. the
EP0235590A2以2,3-二氢-1H-茚-1-酮肟为原料,用雷尼镍催化,在50psi压力下高压氢化,收率86.4%。该方法用高压氢化反应,操作条件比较苛刻,有一定危险性。 EP0235590A2 uses 2,3-dihydro-1H-inden-1-one oxime as raw material, catalyzed by Raney nickel, high-pressure hydrogenation under 50 psi pressure, and the yield is 86.4%. This method uses high-pressure hydrogenation reaction, and the operating conditions are relatively harsh, which has certain risks. the
CN200510135287.X用2,3-二氢-1H-茚-1-酮与炔丙基胺经还原胺化直接合成雷沙吉兰。该方法虽然步骤简单,一步完成,但是实际反应杂质多,收率低,经济性很差。 CN200510135287.X uses 2,3-dihydro-1H-inden-1-one and propargylamine to directly synthesize rasagiline through reductive amination. Although the method has simple steps and is completed in one step, there are many impurities in the actual reaction, the yield is low, and the economy is very poor. the
CN200610054243.9以2,3-二氢-1H-茚-1-酮为原料,与盐酸羟胺反应生成2,3-二氢-1H-茚-1-酮肟,不经分离,加入铝镍合金和氢氧化钠,还原生成2,3-二氢-1H-茚-1-胺,收率76.5%。该方法使用铝镍合金在氢氧化钠存在下还原2,3-二氢-1H-茚-1-酮肟为2,3-二氢-1H-茚-1-胺,铝镍合金用量很大,还用到比较大量的氢氧化钠,成本较高。 CN200610054243.9 uses 2,3-dihydro-1H-inden-1-one as raw material, reacts with hydroxylamine hydrochloride to generate 2,3-dihydro-1H-inden-1-one oxime, without separation, adds aluminum-nickel alloy And sodium hydroxide, reduction to generate 2,3-dihydro-1H-inden-1-amine, yield 76.5%. The method uses aluminum-nickel alloy to reduce 2,3-dihydro-1H-indene-1-one oxime to 2,3-dihydro-1H-indene-1-amine in the presence of sodium hydroxide, and the amount of aluminum-nickel alloy is large , also use relatively large amount of sodium hydroxide, the cost is higher. the
发明内容 Contents of the invention
本发明在于针对目前合成甲磺酸雷沙吉兰的中间体2,3-二氢-1H-茚-1-胺存在的各种问题,而提供解决以上问题的一种2,3-二氢-1H-茚-1-胺的制备工艺。 The present invention aims to provide a 2,3-dihydro -The preparation technology of 1H-inden-1-amine. the
为达到上述目的,本发明采用如下技术方案: To achieve the above object, the present invention adopts the following technical solutions:
一种2,3-二氢-1H-茚-1-胺的制备工艺,采用2,3-二氢-1H-茚-1-酮肟为原料生产2,3-二氢-1H-茚-1-胺,按式一所示的反应式进行反应合成 A preparation process for 2,3-dihydro-1H-indene-1-amine, using 2,3-dihydro-1H-indene-1-one oxime as raw material to produce 2,3-dihydro-1H-indene- 1-amine, according to the reaction formula shown in formula 1, carry out reaction synthesis
式I Formula I
其工艺步骤为: Its process steps are:
a、在2,3-二氢-1H-茚-1-酮肟溶解在乙醇水溶液中,加入铝汞齐进行还原反应; a. Dissolving 2,3-dihydro-1H-inden-1-one oxime in aqueous ethanol solution, adding aluminum amalgam for reduction reaction;
b、将步骤a中的反应完成的反应物通过固液分离、滤液减压蒸发得到2,3-二氢-1H-茚-1-胺的油状物粗品;可以直接用于雷沙吉兰的合成。 b, the reactant completed by the reaction in step a is separated by solid-liquid, and the filtrate is evaporated under reduced pressure to obtain the oily crude product of 2,3-dihydro-1H-indene-1-amine; it can be directly used in the production of rasagiline synthesis. the
所述工艺步骤还包括步骤c: Described processing step also comprises step c:
c、将步骤b中的油状物粗品可减压蒸馏获得2,3-二氢-1H-茚-1-胺的纯品。 c. The crude oil product in step b can be distilled under reduced pressure to obtain the pure product of 2,3-dihydro-1H-inden-1-amine. the
所述步骤a中的反应温度为20℃-90℃,温度太低,反应慢,温度高于90℃,容易发生副反应,优选反应温度在50℃-80℃之间。 The reaction temperature in the step a is 20°C-90°C, if the temperature is too low, the reaction will be slow, if the temperature is higher than 90°C, side reactions will easily occur, preferably the reaction temperature is between 50°C-80°C. the
所述步骤a中乙醇水溶液中乙醇含量为10-98%,因为含量为太低乙醇水溶液虽然可以发生反应,由于1-茚肟在水中溶解性不好,而且铝汞齐在纯水中消耗太快,加大试剂消耗;含量为太高乙醇水溶液,反应速度较慢,反应时间较长,较佳的乙醇水溶液中乙醇含量在80-95%之间,铝汞齐消耗和反应速度都比较适中。 The content of ethanol in the ethanol aqueous solution in described step a is 10-98%, because the content is too low, although the ethanol aqueous solution can react, because 1-indoxime has poor solubility in water, and aluminum amalgam consumes too much in pure water. Fast, increase reagent consumption; if the content is too high in ethanol aqueous solution, the reaction speed is slower and the reaction time is longer. The ethanol content in the better ethanol aqueous solution is between 80-95%, and the aluminum amalgam consumption and reaction speed are relatively moderate . the
所述步骤a铝汞齐用量以金属铝计为完成还原反应理论量的1-1.5倍,低于1倍用量,则反应进行不彻底;高于1.5倍,反应收率不能显著的提高,加大了试剂消耗,并增加了处理难度,优选1.05-1.2倍。 The amount of aluminum amalgam in the step a is calculated as 1-1.5 times of the theoretical amount of the reduction reaction in terms of metal aluminum. If the amount is lower than 1 time, the reaction will not be carried out thoroughly; if it is higher than 1.5 times, the reaction yield cannot be significantly improved. Greater reagent consumption, and increased processing difficulty, preferably 1.05-1.2 times. the
所述步骤a中反应完成以经薄层色谱进行判定。 The completion of the reaction in step a is judged by thin layer chromatography. the
所述铝汞齐的制备,为采用金属铝为原料,浸泡在可溶性汞盐溶液里浸泡1-10分钟,当金属铝表面有少量气泡产生,倒掉水溶液,将制备的铝汞齐用纯水洗涤即得。 The preparation of the aluminum amalgam is to use metal aluminum as a raw material, soak in a soluble mercury salt solution for 1-10 minutes, when a small amount of bubbles are generated on the surface of the metal aluminum, pour off the aqueous solution, and use pure water to prepare the aluminum amalgam. Wash and serve. the
本发明的合成甲磺酸雷沙吉兰的中间体2,3-二氢-1H-茚-1-胺的制备工艺,采用2,3-二氢-1H-茚-1-酮肟在乙醇水溶液中用铝汞齐还原制得2,3-二氢-1H-茚 -1-胺,达到低成本合成2,3-二氢-1H-茚-1-胺的目的,本发明工艺具有工艺简单,成本低廉,操作简易,无危险性,收率高的特点。 The preparation technology of the intermediate 2 of the synthetic rasagiline mesylate of the present invention, 3-dihydro-1H-indene-1-amine, adopts 2,3-dihydro-1H-indene-1-one oxime in ethanol In the aqueous solution, 2,3-dihydro-1H-indene-1-amine is obtained by reduction with aluminum amalgam, and the purpose of low-cost synthesis of 2,3-dihydro-1H-indene-1-amine is achieved. The process of the present invention has the advantages of Simple, low cost, easy to operate, no danger, and high yield. the
具体实施方式 Detailed ways
下面结合具体实施例对本发明进行进一步说明: The present invention will be further described below in conjunction with specific embodiment:
步骤a:在装有机械搅拌器和水浴恒温的500ml烧瓶中加入2,3-二氢-1H-茚-1-酮肟14.72g(0.1mol),加入85%乙醇溶液150ml,水浴加热到60℃,保持60℃恒温。在500ml烧杯中加入硫酸汞0.01g,加入100ml水,搅拌溶解,将剪成0.5cm×0.5cm左右的铝片4.32g(0.16mol)加入到配置好的硫酸汞溶液中,用玻璃棒搅拌1分钟,将铝片用溶液完全浸润,观察铝片上有微小的气泡产生,倾出硫酸汞溶液,用清水将制备好的铝汞齐洗涤两次,制得铝汞齐。将铝汞齐加入到烧瓶中,反应1小时后,用薄层色谱检测2,3-二氢-1H-茚-1-酮肟转化完毕; Step a: Add 14.72 g (0.1 mol) of 2,3-dihydro-1H-inden-1-one oxime to a 500 ml flask equipped with a mechanical stirrer and a constant temperature water bath, add 150 ml of 85% ethanol solution, and heat to 60 ℃, keep a constant temperature of 60 ℃. Add 0.01g of mercury sulfate into a 500ml beaker, add 100ml of water, stir to dissolve, add 4.32g (0.16mol) of aluminum sheet cut into about 0.5cm×0.5cm into the prepared mercury sulfate solution, stir with a glass rod for 1 Minutes, completely infiltrate the aluminum sheet with the solution, observe tiny air bubbles on the aluminum sheet, pour out the mercury sulfate solution, and wash the prepared aluminum amalgam twice with clean water to obtain the aluminum amalgam. Aluminum amalgam is added in the flask, and after reacting for 1 hour, detect 2,3-dihydro-1H-inden-1-one oxime conversion with thin-layer chromatography;
步骤b:将步骤a反应物料冷却到室温,过滤,滤饼用乙醇洗涤,滤液和洗液合并,减压蒸发除去乙醇水溶液,得到12.9g淡黄色油状物,检测得HPLC纯度98.9%。 Step b: Cool the reaction material in step a to room temperature, filter, wash the filter cake with ethanol, combine the filtrate and washing liquid, and evaporate the aqueous ethanol solution under reduced pressure to obtain 12.9 g of light yellow oil, with a purity of 98.9% by HPLC. the
步骤c:将步骤b中的油状物粗品可减压蒸馏获得HPLC纯度99.99%的2,3-二氢-1H-茚-1-胺的纯品。 Step c: The crude oil product in step b can be distilled under reduced pressure to obtain pure 2,3-dihydro-1H-inden-1-amine with an HPLC purity of 99.99%. the
下面介绍通过本发明工艺制备的2,3-二氢-1H-茚-1-胺进行甲磺酸雷沙吉兰的制取,反应式如式III所示: Introduce below by 2,3-dihydro-1H-indene-1-amine that process of the present invention prepares and carry out the preparation of rasagiline mesylate, reaction formula is as shown in formula III:
式III Formula III
步骤如下: Proceed as follows:
步骤1、雷沙吉兰酒石酸盐的制备 Step 1, the preparation of rasagiline tartrate
将实施例b或c中制备的2,3-二氢-1H-茚-1-胺油状物13.32g(0.1mol)加入到500ml烧瓶中,加入100ml二氯甲烷,搅拌溶解,冰水浴冷却至-4℃,加入8%氢氧化钠水溶液100ml,加入对甲苯磺酸丙炔酯21.03g(0.1mol),搅拌10分钟,水浴加热回流2小时,薄层色谱检测反应完成,将反应液冷却至室温,分液,二氯甲烷层用饱和氯化钠溶液100ml洗涤,用10g无水硫酸镁干燥,干燥完毕,过滤,滤液减压蒸发,得到浅棕黄色油状物,将油状物加入到250ml烧瓶中,加入50ml异丙醇,搅拌溶解,加入L-酒石酸9.31g(0.05mol),加热至完全溶解,冷却至室温,继续搅拌3小时,析出白色固体,过滤干燥,得到白色固体粉末10.22g,以2,3-二氢-1H-茚-1-胺计收率41.05%。HPLC纯度99.5%。熔点174.9-176.3℃。 Add 13.32 g (0.1 mol) of 2,3-dihydro-1H-inden-1-amine oily substance prepared in Example b or c into a 500 ml flask, add 100 ml of dichloromethane, stir to dissolve, and cool in an ice-water bath to -4°C, add 100ml of 8% aqueous sodium hydroxide solution, add 21.03g (0.1mol) of propynyl p-toluenesulfonate, stir for 10 minutes, heat and reflux in a water bath for 2 hours, and the thin layer chromatography detects that the reaction is complete, and the reaction solution is cooled to Room temperature, liquid separation, dichloromethane layer washed with 100ml of saturated sodium chloride solution, dried with 10g of anhydrous magnesium sulfate, after drying, filtered, and the filtrate was evaporated under reduced pressure to obtain a light brown oil, which was added to a 250ml flask Add 50ml of isopropanol, stir to dissolve, add 9.31g (0.05mol) of L-tartaric acid, heat until completely dissolved, cool to room temperature, continue stirring for 3 hours, a white solid precipitates, filter and dry to obtain 10.22g of white solid powder, The yield is 41.05% based on 2,3-dihydro-1H-inden-1-amine. HPLC purity 99.5%. The melting point is 174.9-176.3°C. the
步骤2、甲磺酸雷沙吉兰的制备 Step 2, the preparation of rasagiline mesylate
在500ml烧瓶中加入雷沙吉兰L-酒石酸盐9.85g(0.02mol),加入50ml异丙醇,冰浴冷却到-4℃,滴入甲磺酸3.85g(0.04mol),继续搅拌10分钟,水浴加热至固体全部溶解,冷却至室温,析出白色固体,过滤,干燥,得甲磺酸雷沙吉兰8.66g,收率81%。熔点150.1-151.0℃。 Add 9.85g (0.02mol) of rasagiline L-tartrate into a 500ml flask, add 50ml of isopropanol, cool to -4°C in an ice bath, drop in 3.85g (0.04mol) of methanesulfonic acid, and continue stirring for 10 minutes , heated in a water bath until all the solids were dissolved, cooled to room temperature, a white solid was precipitated, filtered, and dried to obtain 8.66 g of rasagiline mesylate, with a yield of 81%. The melting point is 150.1-151.0°C. the
以上所述实施例,只是本发明的较佳实例,并非来限制本发明的实施范围,故凡依本发明申请专利范围所述的构造、特征及原理所做的等效变化或修饰,均应包括于本发明专利申请范围内。 The above-described embodiments are only preferred examples of the present invention, and are not intended to limit the scope of the present invention, so all equivalent changes or modifications made according to the structure, features and principles described in the patent scope of the present invention should be Included in the patent application scope of the present invention. the
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100099450A CN102675122A (en) | 2012-01-12 | 2012-01-12 | A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100099450A CN102675122A (en) | 2012-01-12 | 2012-01-12 | A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102675122A true CN102675122A (en) | 2012-09-19 |
Family
ID=46807747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100099450A Pending CN102675122A (en) | 2012-01-12 | 2012-01-12 | A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102675122A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003048151A1 (en) * | 2001-12-06 | 2003-06-12 | Posco | Method for preparing chiral amines |
CN101062897A (en) * | 2006-04-25 | 2007-10-31 | 重庆医药工业研究院有限责任公司 | Improved process for preparing 2,3-dihydro-1H-indenes-1-amine and derivative thereof |
-
2012
- 2012-01-12 CN CN2012100099450A patent/CN102675122A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003048151A1 (en) * | 2001-12-06 | 2003-06-12 | Posco | Method for preparing chiral amines |
CN101062897A (en) * | 2006-04-25 | 2007-10-31 | 重庆医药工业研究院有限责任公司 | Improved process for preparing 2,3-dihydro-1H-indenes-1-amine and derivative thereof |
Non-Patent Citations (2)
Title |
---|
孙汝淑: "DCK简化结构类似物的合成及其HIV和VEGF抑制活性的探索", 《复旦大学博士学位论文》 * |
孟艳秋等: "1-氨基茚的合成", 《中国新药杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109400556A (en) | A kind of synthetic method of D- (-)-pantoic acid lactone | |
CN100591649C (en) | Method of preparing R-(+)-3-chlorophenylpropanol | |
CN102391253A (en) | Synthetic technology of azelastine hydrochloride | |
CN1240668C (en) | Method for preparing memantine hydrochloride | |
CN101704755A (en) | Method for preparing p-tert-butylbenzylamine | |
CN102675122A (en) | A kind of preparation technology of 2,3-dihydro-1H-inden-1-amine | |
CN102140084A (en) | A kind of production method of trimetazidine and its hydrochloride | |
CN109180532B (en) | High-efficiency preparation method of D-dencichine | |
CN103058985A (en) | Novel process for preparing rotigotine | |
CN104311471A (en) | Improved mitiglinide calcium industrialized preparation method | |
CN103382159A (en) | Venlafaxine hydrochloride preparation method | |
CN113801027B (en) | Synthesis process of dapoxetine hydrochloride | |
CN104744537A (en) | Synthetic method of capecitabine | |
CN103214389A (en) | Application of N, N'-dual-fatty acyl group ethanediamine sodium malonate compounded system in tertiary oil recovery | |
CN104945270B (en) | A kind of synthetic method of L-dopa methyl ester hydrochloride | |
CN103981248B (en) | A kind of leucic method of resolution of racemic | |
CN103435530B (en) | Preparation method of D-tryptophan lower alcohol ester hydrochloride with high optical purity | |
CN103896784A (en) | Method for reducing nitro of Fingolimod intermediate to amino | |
CN102962004B (en) | Glucosamide surfactant and method for preparing same | |
CN104163811A (en) | New method for preparation of duloxetine hydrochloride | |
CN110776429A (en) | Improved preparation method of rasagiline racemic intermediate | |
CN101972615B (en) | Glycosyl-contained surface active agent as well as preparation method and measuring method thereof | |
CN103319374B (en) | Asymmetric synthetic method of (S)-rivastigmine | |
CN102731287B (en) | Refined monochloroacetic acid crystalline product complexometric extraction method | |
CN109060473A (en) | A kind of preparation method of ambroxol hydrochloride impurity reference substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120919 |